{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:18:45Z","timestamp":1790993925268,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11894-016-0491-3","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:52:46Z","timestamp":1457311966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)"],"prefix":"10.1007","volume":"18","author":[{"given":"Mathieu","family":"Uzzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibin M.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mehandru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"issue":"1","key":"491_CR1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. ICON: common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38\u201359.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"491_CR2","doi-asserted-by":"crossref","unstructured":"Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015. Epub ahead of print.","DOI":"10.1007\/s10875-015-0201-1"},{"key":"491_CR3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650\u20137.","journal-title":"Blood"},{"key":"491_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar4032","volume":"14","author":"U Salzer","year":"2012","unstructured":"Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency: an update. Arthritis Res Ther. 2012;14:223.","journal-title":"Arthritis Res Ther"},{"key":"491_CR5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","volume":"46","author":"E Oksenhendler","year":"2008","unstructured":"Oksenhendler E, G\u00e9rard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547\u201354.","journal-title":"Clin Infect Dis"},{"key":"491_CR6","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","volume":"105","author":"G Malamut","year":"2010","unstructured":"Malamut G, Verkarre V, Suarez F, Viallard J-F, Lascaux A-S, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105:2262\u201375. \u2022\u202250 patients with CVID-associated GI symptoms were assessed with chronic diarrhea as the most frequent clinical feature (92%). Pathological small bowel assessment was remarkable for the high frequency of increased IEL (75%) and villous atrophy (50%) whereas plasma cells were almost always absent. IVIg desmonstrated no effect on GI symptoms.","journal-title":"Am J Gastroenterol"},{"key":"491_CR7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","volume":"31","author":"JA Daniels","year":"2007","unstructured":"Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31:1800\u201312.","journal-title":"Am J Surg Pathol"},{"key":"491_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000355957","volume":"163","author":"P Kralickova","year":"2014","unstructured":"Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol. 2014;163:69\u201374.","journal-title":"Int Arch Allergy Immunol"},{"key":"491_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","volume":"41","author":"J Salcedo","year":"1997","unstructured":"Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997;41:366\u201370.","journal-title":"Gut"},{"key":"491_CR10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ajg.2014.432","volume":"110","author":"JM Woodward","year":"2015","unstructured":"Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol Nature Publishing Group. 2015;110:320\u20137. \u2022\u2022Stools and small bowel biopsies from 8 CVID patients with CE were analysed by PCR for the presence of Norovirus RNA and compared to 10 CVID patients without GI disorder. All 8 patients with CVID-associated CE showed evidence of chronic Norovirus carriage (none in the control group). Remarkably, 3 patients with Norovirus clearance (one spontaneously, 2 with Ribavirin therapy) exhibited complete symptomatic and histological recovery.","journal-title":"Am J Gastroenterol. Nature Publishing Group"},{"key":"491_CR11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s10875-014-0087-3","volume":"34","author":"AAJM Ven van de","year":"2014","unstructured":"van de Ven AAJM, Janssen WJM, Schulz LS, van Loon AM, Voorkamp K, Sanders EAM, et al. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies. J Clin Immunol. 2014;34:962\u201370.","journal-title":"J Clin Immunol"},{"key":"491_CR12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0032-1326078","volume":"45","author":"L Maarschalk-Ellerbroek","year":"2013","unstructured":"Maarschalk-Ellerbroek L, Oldenburg B, Mombers I, Hoepelman A, Brosens L, Offerhaus G, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45:320\u20133.","journal-title":"Endoscopy"},{"issue":"3","key":"491_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/apt.13474","volume":"43","author":"SE Roberts","year":"2016","unstructured":"Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG. Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe. Aliment Pharmacol Ther. 2016;43(3):334\u201345.","journal-title":"Aliment Pharmacol Ther"},{"key":"491_CR14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/315384","volume":"181","author":"JE Everhart","year":"2000","unstructured":"Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359\u201363.","journal-title":"J Infect Dis"},{"key":"491_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.45.1.77","volume":"45","author":"A Zullo","year":"1999","unstructured":"Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45:77\u201381.","journal-title":"Gut"},{"key":"491_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2249.2009.03909.x","volume":"156","author":"IME Desar","year":"2009","unstructured":"Desar IME, van Deuren M, Sprong T, Jansen JBMJ, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156:434\u20139.","journal-title":"Clin Exp Immunol"},{"key":"491_CR17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","volume":"20","author":"K Washington","year":"1996","unstructured":"Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20:1240\u201352.","journal-title":"Am J Surg Pathol"},{"key":"491_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ibd.21376","volume":"17","author":"S Agarwal","year":"2011","unstructured":"Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17:251\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"491_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277\u201386.","journal-title":"Blood"},{"key":"491_CR20","doi-asserted-by":"crossref","unstructured":"Gathmann B, Mahlaoui N, G\u00e9rard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116\u201326.e11.","DOI":"10.1016\/j.jaci.2013.12.1077"},{"key":"491_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34\u201348.","journal-title":"Clin Immunol"},{"key":"491_CR22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2006.06.022","volume":"131","author":"PJ Mannon","year":"2006","unstructured":"Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131:748\u201356.","journal-title":"Gastroenterology"},{"key":"491_CR23","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart DC, Sandborn WJ. Crohn\u2019s disease. Lancet Elsevier Ltd. 2012;380:1590\u2013605.","journal-title":"Lancet. Elsevier Ltd"},{"key":"491_CR24","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa033402","volume":"351","author":"PJ Mannon","year":"2004","unstructured":"Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, et al. Anti-interleukin-12 antibody for active Crohn\u2019s disease. N Engl J Med. 2004;351:2069\u201379.","journal-title":"N Engl J Med"},{"key":"491_CR25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","volume":"367","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Gasink C, Gao L-L, Blank MA, Johanns J, Guzzo C, et al. Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease. N Engl J Med. 2012;367:1519\u201328.","journal-title":"N Engl J Med"},{"key":"491_CR26","doi-asserted-by":"crossref","unstructured":"Peters CP, Mj\u00f6sberg JM, Bernink JH, Spits H. Innate lymphoid cells in inflammatory bowel diseases. Immunol Lett. 2015; doi: 10.1016\/j.imlet.2015.10.004 .","DOI":"10.1016\/j.imlet.2015.10.004"},{"key":"491_CR27","unstructured":"Cols M, Rahman A, Maglione PJ, Garcia-Carmona Y, Simchoni N, Ko H-BM, et al. Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J Allergy Clin Immunol. 2015; \u2022\u2022Lymphoid cells were identified and analyzed from peripheral blood and GI tissue of CVID patients (31 with and 24 without inflammatory\/autoimmune complications). In the blood of CVID patients with inflammatory associated disorders, type 3 ILC and -associated cytokines were expanded. Moreover, numerous IFN\u03b3 + ROR\u03b3t + CD3 - were found in GI biopsies of patients with IBD-like suggesting a role in this mucosal inflammation."},{"key":"491_CR28","first-page":"2641","volume":"19","author":"M Sanges","year":"2015","unstructured":"Sanges M, Spadaro G, Miniero M, Mattera D, Sollazzo R, D\u2019Armiento FP, et al. Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn\u2019s-like phenotype: report of a case. Eur Rev Med Pharmacol Sci. 2015;19:2641\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"491_CR29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/gut.31.8.879","volume":"31","author":"C Pignata","year":"1990","unstructured":"Pignata C, Budillon G, Monaco G, Nani E, Cuomo R, Parrilli G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990;31:879\u201382.","journal-title":"Gut"},{"key":"491_CR30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1309\/AJCPEIILH2C0WFYE","volume":"138","author":"F Biagi","year":"2012","unstructured":"Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol. 2012;138:185\u20139.","journal-title":"Am J Clin Pathol"},{"key":"491_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","volume":"33","author":"J-N Boursiquot","year":"2013","unstructured":"Boursiquot J-N, G\u00e9rard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33:84\u201395.","journal-title":"J Clin Immunol"},{"key":"491_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","volume":"133","author":"O Ardeniz","year":"2009","unstructured":"Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol. 2009;133:198\u2013207.","journal-title":"Clin Immunol"},{"key":"491_CR33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","volume":"33","author":"NM Chase","year":"2012","unstructured":"Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2012;33:30\u20139.","journal-title":"J Clin Immunol"},{"key":"491_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/asheducation.V2012.1.301.3798316","volume":"2012","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program. 2012;2012:301\u20135.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"491_CR35","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00000478-199212000-00004","volume":"16","author":"CA Sander","year":"1992","unstructured":"Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16:1170\u201382.","journal-title":"Am J Surg Pathol"},{"key":"491_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","volume":"165","author":"F Dhalla","year":"2011","unstructured":"Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1\u20137.","journal-title":"Clin Exp Immunol"},{"key":"491_CR37","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1572-0241.2000.02074.x","volume":"95","author":"M Cassaro","year":"2000","unstructured":"Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431\u20138.","journal-title":"Am J Gastroenterol"},{"key":"491_CR38","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1066896914532540","volume":"22","author":"G Petris De","year":"2014","unstructured":"De Petris G, Dhungel BM, Chen L, Chang Y-HH. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol. 2014;22:600\u20136.","journal-title":"Int J Surg Pathol"},{"key":"491_CR39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2007.03481.x","volume":"150","author":"I Chua","year":"2007","unstructured":"Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2007;150:306\u201311.","journal-title":"Clin Exp Immunol"},{"key":"491_CR40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4321\/S1130-01082013000500010","volume":"105","author":"JM V\u00e1zquez-Mor\u00f3n","year":"2013","unstructured":"V\u00e1zquez-Mor\u00f3n JM, Pallar\u00e9s-Manrique H, Mart\u00edn-Su\u00e1rez IJ, Ben\u00edtez-Rodr\u00edguez B, Ramos-Lora M. Crohn\u2019s-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab. Rev Esp Enferm Dig. 2013;105:299\u2013302.","journal-title":"Rev Esp Enferm Dig"},{"key":"491_CR41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","volume":"27","author":"SM Holland","year":"2013","unstructured":"Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27:89\u201399. viii.","journal-title":"Hematol Oncol Clin North Am"},{"key":"491_CR42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155\u201369.","journal-title":"Medicine (Baltimore)"},{"key":"491_CR43","doi-asserted-by":"crossref","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","volume":"4","author":"JM Berg van den","year":"2009","unstructured":"van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.","journal-title":"PLoS One"},{"key":"491_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","volume":"152","author":"LBKR Jones","year":"2008","unstructured":"Jones LBKR, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211\u20138.","journal-title":"Clin Exp Immunol"},{"key":"491_CR45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","volume":"126","author":"B Martire","year":"2008","unstructured":"Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126:155\u201364.","journal-title":"Clin Immunol"},{"key":"491_CR46","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s10875-013-9940-z","volume":"33","author":"M Raptaki","year":"2013","unstructured":"Raptaki M, Varela I, Spanou K, Tzanoudaki M, Tantou S, Liatsis M, et al. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2013;33:1302\u20139.","journal-title":"J Clin Immunol"},{"key":"491_CR47","doi-asserted-by":"crossref","unstructured":"Magnani A, Brosselin P, Beaut\u00e9 J, de Vergnes N, Mouy R, Debr\u00e9 M, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134:655\u201362.e8. \u2022\u202268 on 98 analyzed CGD patients experienced inflammatory episodes. GI tract was the most commonly affected organ (88% of episodes) and patients with X-linked CGD were at higher risk of inflammatory episodes compared to patients with autosomal-recessive CGD (RR 2.2, 95% CI\u2009=\u20091.5-3.5).","DOI":"10.1016\/j.jaci.2014.04.014"},{"key":"491_CR48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1463-1318.2006.01030.x","volume":"8","author":"A Huang","year":"2006","unstructured":"Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis. 2006;8:637\u201344.","journal-title":"Colorectal Dis"},{"key":"491_CR49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.114.2.462","volume":"114","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O\u2019Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462\u20138.","journal-title":"Pediatrics"},{"key":"491_CR50","doi-asserted-by":"crossref","unstructured":"Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, et al. High levels of Crohn\u2019s disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol. Elsevier Inc.; 2011;138:14\u201322.","DOI":"10.1016\/j.clim.2010.08.003"},{"key":"491_CR51","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.ppat.0020028","volume":"2","author":"DE Greenberg","year":"2006","unstructured":"Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, et al. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog. 2006;2:e28.","journal-title":"PLoS Pathog"},{"key":"491_CR52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ajg.2008.72","volume":"104","author":"DJB Marks","year":"2009","unstructured":"Marks DJB, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn\u2019s disease. Am J Gastroenterol. 2009;104:117\u201324.","journal-title":"Am J Gastroenterol"},{"key":"491_CR53","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/PAS.0b013e318297427d","volume":"37","author":"M Alimchandani","year":"2013","unstructured":"Alimchandani M, Lai J-P, Aung PP, Khangura S, Kamal N, Gallin JI, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365\u201372.","journal-title":"Am J Surg Pathol"},{"key":"491_CR54","unstructured":"Khangura SK, Kamal N, Ho N, Quezado M, Zhao X, Marciano B, et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. Elsevier Ltd; 2015; \u2022\u2022211 GI tract endoscopies were performed at the NIH on 78 CGD patients.. Inflammatory lesions were frequent in all parts of the GI tract with a classically skip pattern. Ano-rectal area was the most often involved GI tract part (93% of patients with colonic inflammation) including sometimes fistulae."},{"key":"491_CR55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2013.04.059","volume":"132","author":"N Noel","year":"2013","unstructured":"Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132:997\u20131000. e1\u20134.","journal-title":"J. Allergy Clin. Immunol"},{"key":"491_CR56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3476(95)70519-8","volume":"126","author":"JR Rosh","year":"1995","unstructured":"Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr. 1995;126:143\u20135.","journal-title":"J Pediatr"},{"key":"491_CR57","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","volume":"51","author":"G Uzel","year":"2010","unstructured":"Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429\u201334.","journal-title":"Clin Infect Dis"},{"key":"491_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/gut.42.1.127","volume":"42","author":"B Myrup","year":"1998","unstructured":"Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut. 1998;42:127\u201330.","journal-title":"Gut"},{"key":"491_CR59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T G\u00fcng\u00f6r","year":"2014","unstructured":"G\u00fcng\u00f6r T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet (London, England). 2014;383:436\u201348.","journal-title":"Lancet (London, England)"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-016-0491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-016-0491-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-016-0491-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T15:37:46Z","timestamp":1600270666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-016-0491-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1007\/s11894-016-0491-3","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]},"article-number":"17"}}